PDCD1 and breast cancer: Similar results were also found in a previous study [25], which indicated that ER-negative (4.35 vs. 1.82, P < 0.001) and PR-negative (3.47 vs. 1.86, P < 0.001) BC patients had higher PD-1 expression than that in ER-positive and PR-positive patients.